June 1, 2016 / 3:58 PM / 2 years ago

BUZZ-Valeant Pharmaceuticals: To report Q1 results on June 7

** Canadian drugmaker’s U.S.-listed shares up 8.4 pct at $30.85

** Company says will host conference call on June 7 to discuss Q1 results and reiterated it expects to file its quarterly report with U.S. and Canadian regulators on or before June 10, ahead of a July 31 deadline

** “Although visibility remains low for Valeant’s business, we forecast that the company should finish 1Q16 at the top half of its guidance,” BMO Capital Markets analyst writes in note

** Michael Pearson, the former chief executive of Valeant, will receive a $9 million severance payment and agreed to a consulting agreement worth hundreds of thousands of dollars, according to a document filed with regulators

** “We believe this is positive because it should facilitate the transition for Valeant’s new CEO,” BMO writes

** Up to Tuesday’s close, stock had fallen 72 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below